Brought to you by 
Ilypsa raises $36mm with Series B venture round
30 Aug 2005
Executive Summary
Biopharmaceutical company Ilypsa (formerly Symyx Therapeutics, a 2003 spin-out from Symyx Technologies) raised $36mm in a Series B round co-led by new investors US Venture Partners, Johnson & Johnson Development Corp., and Delphi Ventures. Also participating in the financing were other new investors CMEA Ventures and Mediphase Venture Partners, along with existing backers Sprout Group and 5AM Ventures.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com